Demographics of pwCF who underwent colonoscopy
| Demographic variables | |
| Number of pwCF aged ≥30 years who underwent colonoscopy between 2010 and 2020 | 33 |
| Mean age at colonoscopy (±SD), years | 44.8 (±11.0) |
| Male (%) | 23 (70%) |
| ppFEV1 (±SD), % | 45.4 (±22.4)% |
| Phe508del homozygotes (%) | 16 (48%) |
| CFTR modulator treatment (%) | 11 (33%) |
CFTR, CF transmembrane conductance regulator; FEV1, forced expiratory volume in one second; pp, percent predicted; pwCF, patients with cystic fibrosis.